Back
ESC Premium Access

Do we follow evidence-based recommendations for NOACs dosing? Results from a nationwide cross-sectional registry.

Session: Poster Session 5 - Atrial fibrillation - Stroke prevention 2
Topic: Oral Anticoagulation
Speaker: Doctor L. Urban (Bratislava, SK)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Lubos Urban

The National Institute of Cardiovascular Diseases, Bratislava (Slovakia)
0 follower

10 more presentations in this session

Antithrombotic management in patients with atrial fibrillation and acute coronary syndromes

Speaker: Associate Professor B. Hudzik (Zabrze, PL)

Access
Abstract
Slides
Thumbnail

Advantage of novel oral anticoagulants compared to vitamin-K antagonist in atrial fibrillation. Data from real world.

Speaker: Doctor G. Simonyi (Budapest, HU)

Access
Abstract
Slides
Thumbnail

Prior antithrombotic therapy: a snapshot of 17,769 patients from the global edoxaban treatment in routine clinical practice in patients with non-valvular atrial fibrillation programme (global ETNA-AF)

Speaker: Professor R. De Caterina (Pisa, IT)

Access
Abstract
Slides
Thumbnail

Oral anticoagulation continuation vs. discontinuation after catheter-ablation of paroxysmal atrial fibrillation - incidence of cerebral insults and severe hemorrhagic complications

Speaker: Ms L. Pracht (Munich, DE)

Access
Abstract
Thumbnail

A new score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs

Speaker: Doctor O. Rutherford (Sarpsborg, NO)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 5 - Atrial fibrillation - Stroke prevention 2

Speakers: Doctor L. Urban, Associate Professor B. Hudzik, Doctor G. Simonyi, Professor R. De Caterina, Ms L. Pracht...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb